| Hans-Günter Meyer-Thompson | international
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19.
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19.
Rosales R, Janssen T, Yermash J, Yap KR, Ball EL, Hartzler B, Garner BR, Becker SJ.
J Subst Abuse Treat. 2021 Oct 30;132:108648. doi: 10.1016/j.jsat.2021.108648. Epub ahead of print. PMID: 34742607; PMCID: PMC8566093.